{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T13:49:55Z","timestamp":1764510595360},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4]]},"abstract":"<jats:p>The spectrum of bone marrow lesions in patients with nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) has not been evaluated systematically. In this study, we analyzed a cohort of 262 NLPHL patients who underwent staging bone marrow evaluation or targeted bone biopsy as a part of their initial diagnostic workup, among which lymphoma was detected in 24 (9.2%) patients. Eleven patients had bone marrow findings of NLPHL (few large B cells in a background of small B cell and T cell), and 13 patients had either T-cell\/histiocyte-rich large B-cell lymphoma (large B cells in a background of T cells and histiocytes) or typical diffuse large B-cell lymphoma (sheets of large B cells). Bone marrow involvement was more common in patients with variant NLPHL histologic patterns in the lymph node as compared with those who had classic patterns (12\/18 vs. 4\/16; <jats:italic toggle=\"yes\">P=<\/jats:italic>0.02). An additional 27 NLPHL patients had bone marrow specimens involved by lymphoid aggregates composed of small T cells and B cells without large B cells; this subgroup had a longer event-free survival than patients with lymphoma in the bone marrow (145 vs. 35\u2009mo). Disease recurrence or progression was more frequent in patients with bone marrow involvement by either NLPHL or LBCL, compared with patients who had lymphoid aggregates (13\/21 vs. 8\/26; <jats:italic toggle=\"yes\">P=<\/jats:italic>0.04). In conclusion, staging bone marrow sampling detects lymphoma in a sizeable subset of NLPHL patients, particularly those with variant histologic patterns. Lymphoid aggregates lacking large B cells in staging bone marrow specimens from NLPHL patients can be regarded as clinically benign without impact on stage, outcome, or risk stratification.<\/jats:p>","DOI":"10.1097\/pas.0000000000001005","type":"journal-article","created":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T01:59:45Z","timestamp":1515376785000},"page":"492-499","source":"Crossref","is-referenced-by-count":12,"title":["Bone Marrow Involvement in Patients With Nodular Lymphocyte Predominant Hodgkin Lymphoma"],"prefix":"10.1097","volume":"42","author":[{"given":"Rose Lou Marie C.","family":"Agbay","sequence":"first","affiliation":[{"name":"Hematopathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanam","family":"Loghavi","sequence":"additional","affiliation":[{"name":"Hematopathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuang","family":"Zuo","sequence":"additional","affiliation":[{"name":"Hematopathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Fayad","sequence":"additional","affiliation":[{"name":"Lymphoma\/Myeloma"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bouthaina","family":"Dabaja","sequence":"additional","affiliation":[{"name":"Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[{"name":"Hematopathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph D.","family":"Khoury","sequence":"additional","affiliation":[{"name":"Hematopathology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230922","first-page":"1889","article-title":"European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes","volume":"96","author":"Anagnostopoulos","year":"2000","journal-title":"Blood"},{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00277-015-2578-6","article-title":"A 20-year population-based study on the epidemiology, clinical features, treatment, and outcome of nodular lymphocyte predominant Hodgkin lymphoma","volume":"95","author":"Strobbe","year":"2016","journal-title":"Ann Hematol"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.3109\/10428194.2011.584993","article-title":"Nodular lymphocyte predominant Hodgkin lymphoma behaves as a distinct clinical entity with good outcome: evidence from 14-year follow-up in the West of Scotland Cancer Network","volume":"52","author":"Farrell","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1200\/JCO.2009.24.9516","article-title":"Transformation to aggressive lymphoma in nodular lymphocyte-predominant Hodgkin\u2019s lymphoma","volume":"28","author":"Al-Mansour","year":"2010","journal-title":"J Clin Oncol"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/cncr.24819","article-title":"Nodular, lymphocyte-predominant Hodgkin lymphoma: a long-term study and analysis of transformation to diffuse large B-cell lymphoma in a cohort of 164 patients from the Adult Lymphoma Study Group","volume":"116","author":"Biasoli","year":"2010","journal-title":"Cancer"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1200\/JCO.2009.24.0945","article-title":"Early-stage, lymphocyte-predominant Hodgkin\u2019s lymphoma: patient outcomes from a large, single-institution series with long follow-up","volume":"28","author":"Chen","year":"2010","journal-title":"J Clin Oncol"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1002\/cncr.10404","article-title":"European Organization for Research and Treatment of Cancer and Groupe d\u2019Etude des Lymphomes de l\u2019Adulte very favorable and favorable, lymphocyte-predominant Hodgkin disease","volume":"94","author":"Wilder","year":"2002","journal-title":"Cancer"},{"key":"R9-20230922","first-page":"1063","article-title":"The pathology and nomenclature of Hodgkin\u2019s disease","volume":"26","author":"Lukes","year":"1966","journal-title":"Cancer Res"},{"key":"R10-20230922","first-page":"963","article-title":"Nodular lymphocyte predominance type of Hodgkin\u2019s disease is a B cell lymphoma","volume":"186","author":"Poppema","year":"1985","journal-title":"Adv Exp Med Biol"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/00000478-200404000-00008","article-title":"Bone marrow involvement in patients with nodular lymphocyte predominant Hodgkin lymphoma","volume":"28","author":"Khoury","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3109\/10428194.2014.916802","article-title":"Bone marrow involvement in nodular lymphocyte predominant Hodgkin lymphoma occurs in tumors with a variant pattern","volume":"56","author":"Panjwani","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/bjh.14518","article-title":"Advanced stage nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents: clinical characteristics and treatment outcome\u2014a report from the SFCE & CCLG groups","volume":"177","author":"Shankar","year":"2017","journal-title":"Br J Haematol"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1200\/JCO.2007.11.8869","article-title":"Lymphocyte-predominant and classical Hodgkin\u2019s lymphoma: a comprehensive analysis from the German Hodgkin Study Group","volume":"26","author":"Nogova","year":"2008","journal-title":"J Clin Oncol"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization (WHO) classification of lymphoid neoplasms","volume":"27","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1097\/00000478-200310000-00007","article-title":"Characterization of variant patterns of nodular lymphocyte predominant hodgkin lymphoma with immunohistologic and clinical correlation","volume":"27","author":"Fan","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R17-20230922","article-title":"Validation of immunohistochemical assays for integral biomarkers in the NCI-MATCH EAY131 clinical trial","author":"Khoury","year":"2017","journal-title":"Clin Cancer Res"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1182\/blood-2013-07-515825","article-title":"The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)","volume":"122","author":"Hartmann","year":"2013","journal-title":"Blood"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-2559.2003.01634.x","article-title":"Follicular\u2019 pattern of bone marrow involvement in lymphocyte-predominant Hodgkin\u2019s disease","volume":"43","author":"Pillai","year":"2003","journal-title":"Histopathology"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201804000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T22:38:47Z","timestamp":1695422327000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201804000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001005","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]}}}